1. Home
  2. FATE vs FSBW Comparison

FATE vs FSBW Comparison

Compare FATE & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • FSBW
  • Stock Information
  • Founded
  • FATE 2007
  • FSBW 1936
  • Country
  • FATE United States
  • FSBW United States
  • Employees
  • FATE N/A
  • FSBW N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • FSBW Banks
  • Sector
  • FATE Health Care
  • FSBW Finance
  • Exchange
  • FATE Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • FATE 406.5M
  • FSBW 355.0M
  • IPO Year
  • FATE 2013
  • FSBW 2012
  • Fundamental
  • Price
  • FATE $1.27
  • FSBW $40.75
  • Analyst Decision
  • FATE Hold
  • FSBW Hold
  • Analyst Count
  • FATE 10
  • FSBW 1
  • Target Price
  • FATE $6.75
  • FSBW $44.00
  • AVG Volume (30 Days)
  • FATE 3.2M
  • FSBW 15.0K
  • Earning Date
  • FATE 02-24-2025
  • FSBW 01-27-2025
  • Dividend Yield
  • FATE N/A
  • FSBW 2.65%
  • EPS Growth
  • FATE N/A
  • FSBW 8.77
  • EPS
  • FATE N/A
  • FSBW 4.68
  • Revenue
  • FATE $13,447,000.00
  • FSBW $139,457,000.00
  • Revenue This Year
  • FATE N/A
  • FSBW N/A
  • Revenue Next Year
  • FATE N/A
  • FSBW $6.26
  • P/E Ratio
  • FATE N/A
  • FSBW $8.71
  • Revenue Growth
  • FATE N/A
  • FSBW 2.60
  • 52 Week Low
  • FATE $1.04
  • FSBW $30.64
  • 52 Week High
  • FATE $8.83
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.94
  • FSBW 43.60
  • Support Level
  • FATE $1.22
  • FSBW $38.35
  • Resistance Level
  • FATE $1.36
  • FSBW $41.92
  • Average True Range (ATR)
  • FATE 0.15
  • FSBW 1.57
  • MACD
  • FATE -0.02
  • FSBW 0.20
  • Stochastic Oscillator
  • FATE 24.21
  • FSBW 57.04

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: